Embecta (EMBC) vs Orthofix Medical (OFIX)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Orthofix Medical (OFIX) has outperformed Embecta (EMBC) over the past year, losing 37.4% versus a loss of 58.2%. Orthofix Medical is the larger company by market cap ($370.7 million vs $322.1 million), about 1.2 times the size. On valuation, Embecta trades at a lower forward P/E (3.2x vs 24.8x for Orthofix Medical).
Embecta pays a dividend yielding 8.09%, while Orthofix Medical does not currently pay one.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | EMBC | OFIX |
|---|---|---|
| Share price | $5.69 | $9.17 |
| Market cap | $322.11M | $370.67M |
| 1-day change | -1.13% | +1.89% |
| YTD return | -52.15% | -40.63% |
| 1-year return | -58.17% | -37.37% |
| 5-year return | — | -75.17% |
| P/E ratio (TTM) | 3.87 | — |
| Forward P/E | 3.23 | 24.78 |
| EPS (TTM) | $1.47 | $-1.52 |
| Dividend yield | 8.09% | 0.00% |
| Annual dividend | $0.46 | $0.00 |
| 52-week high | $14.91 | $16.99 |
| 52-week low | $2.77 | $8.50 |
| Distance from 52-week high | -61.87% | -46.03% |
| Analyst consensus | none | none |
| Avg. price target upside | -29.64% | +41.77% |
| Average volume | 1.37M | 369.51K |
| Shares outstanding | 56.66M | 40.42M |
| Employees | 1,850 | 1,605 |
| Sector | Health Care | Health Care |
| Industry | Medical/Dental Instruments | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- OFIX has outperformed EMBC by 20.8 percentage points over the past year.
- Embecta offers a meaningfully higher dividend yield (8.09% vs 0.00%).
About Embecta
EMBC stock →Embecta Corp., a medical device company, provides solutions to improve the health and wellbeing of people living with diabetes in the United States and internationally. The company's products include pen needles, syringes, and safety injection devices, as well as digital applications to assist people with managing patient's diabetes.
Health Care · Medical/Dental Instruments · 1,850 employees
About Orthofix Medical
OFIX stock →Orthofix Medical Inc., together with its subsidiaries, operates as a medical technology company in the United States, Italy, the United Kingdom, France, Germany, Brazil, and internationally. It operates through two segments, Global Spine and Global Limb Reconstruction.
Health Care · Medical/Dental Instruments · 1,605 employees
EMBC vs OFIX FAQ
Which is bigger, Embecta or Orthofix Medical?
Orthofix Medical (OFIX) is larger, with a market capitalization of $370.67M compared with $322.11M for Embecta (EMBC).
Which stock has performed better over the past year, EMBC or OFIX?
OFIX returned -37.37% over the past 12 months, compared with -58.17% for EMBC (price return, excluding dividends). Past performance does not predict future results.
Which pays a higher dividend, Embecta or Orthofix Medical?
Embecta pays a dividend yielding 8.09%, while Orthofix Medical does not currently pay a regular dividend.
Are Embecta and Orthofix Medical in the same industry?
Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.